[Place of clinical pharmacist in the management of drugs in patients with hypertension]

Ann Cardiol Angeiol (Paris). 2015 Jun;64(3):216-21. doi: 10.1016/j.ancard.2015.04.003. Epub 2015 Jun 4.
[Article in French]

Abstract

Purpose: To synthesize pharmacists' interventions made in the department of internal medicine and hypertension of university hospital of Toulouse and assess the impact on medication orders.

Methods: This is a single-center, prospective study using pharmacists' interventions recorded between September 2013 and March 2014 on the Act-IP(©) website of the French Society of Clinical Pharmacy. The clinical pharmacist is present everyday in the unit to establish the medication reconciliation of new patients (the process of comparing a patient's medication orders to all of the medications that the patient has been taking), and analysis of medication orders. When a risk of iatrogenic drug is identified, a therapeutic change is proposed to the prescriber.

Results: A total of 2491 medication orders were analyzed for 7 months, leading to 39 pharmacists' interventions (1.6 pharmacists' interventions per 100 medication orders). The most commonly identified drug-related problems were improper administration (33%, n=13), not prescribed drug (21%, n=8), non-conformity to guidelines (18%, n=7), supratherapeutic dose (15%, n=6), and 13% (n=5) targeted prescribed treatment not administered, underdosing, incorrect administration or drug interaction. The most relevant molecules were atorvastatin (10%), bromazepam (8%) and levothyroxine (8%) and only 2 interventions targeted antihypertensive drugs. The rate of physicians' acceptance was 92%.

Conclusion: Pharmacists' interventions mainly concern the co-prescriptions of antihypertensive drugs and very few antihypertensive drugs. The clinical pharmacist contributes to preventing iatrogenic in patients with hypertension with a very good acceptance by the clinician.

Keywords: Analyse pharmaceutique; Co-prescriptions; Conciliation médicamenteuse; Hypertension; Hypertension artérielle; Interventions pharmaceutiques; Medication orders; Medication reconciliation; Pharmaceutical analysis; Pharmacists’ interventions; Prescriptions médicales; Prevention of iatrogenic; Prévention de l’iatrogénie.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Drug Prescriptions / statistics & numerical data*
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Pharmacy Service, Hospital / statistics & numerical data*
  • Prospective Studies

Substances

  • Antihypertensive Agents